Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
, 46 (1), 119-121

Should We Consider Blocking the Inhibitory Immune Checkpoint Molecules for Treating T Cell Exhaustion in Sepsis?

Affiliations
Editorial

Should We Consider Blocking the Inhibitory Immune Checkpoint Molecules for Treating T Cell Exhaustion in Sepsis?

Manu Shankar-Hari et al. Intensive Care Med.

Comment on

Similar articles

See all similar articles

References

    1. Nat Rev Immunol. 2016 Mar;16(3):149-63 - PubMed

References

    1. JAMA. 2016 Feb 23;315(8):801-10 - PubMed

References

    1. BMJ. 2018 Mar 14;360:k793 - PubMed

References

    1. Nat Rev Immunol. 2017 Jul;17(7):407-420 - PubMed

References

    1. J Leukoc Biol. 2016 Dec;100(6):1239-1254 - PubMed

References

    1. JCI Insight. 2018 Mar 8;3(5): - PubMed

References

    1. Intensive Care Med. 2019 Oct;45(10):1360-1371 - PubMed

References

    1. Curr Opin Crit Care. 2019 Oct;25(5):489-497 - PubMed

References

    1. Nat Rev Immunol. 2018 Jun;18(6):363-373 - PubMed

References

    1. PLoS One. 2018 Jun 26;13(6):e0199497 - PubMed

References

    1. Intensive Care Med. 2018 Nov;44(11):1836-1848 - PubMed

References

    1. Nat Rev Immunol. 2015 Aug;15(8):486-99 - PubMed

References

    1. Intensive Care Med. 1999 Jan;25(1):106-9 - PubMed

References

    1. Crit Care Med. 2019 May;47(5):632-642 - PubMed

References

    1. JAMA. 2011 Dec 21;306(23):2594-605 - PubMed

LinkOut - more resources

Feedback